Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination

Ramazan Mercan, Jacob F. Mayer, Denise Walker, Stella Jones, Sergio Oehninger, James P. Toner, Suheil J. Muasher

Research output: Contribution to journalArticle

Abstract

The aim of this study was to compare the efficacy of pure follicle stimulating hormone (FSH) with that of FSH/human menopausal gonadotrophin (HMG) combination in downregulated cycles. A total of 357 patients was evaluated retrospectively. Sixty percent of patients in the FSH group and 55% in the FSH/HMG group were new; the others were repeat patients. Ovulation was suppressed with leuprolide acetate in all patients, followed by either FSH (n = 218) or FSH/HMG (n = 119). There was no difference in patients' age, infertility factors, number of ampoules used, length of stimulation, oestradiol levels on day of human chorionic gonadotrophin (HCG) administration, number of oocytes recovered or the number of embryos transferred. Also, nuclear maturity at aspiration and fertilization rates were not different between the two groups. FSH stimulation resulted in a significantly higher percentage of mature oocytes that showed the typical 'mature' morphological characteristics (P <0.0001). The clinical pregnancy rates per transfer were 40 and 28% in patients stimulated with pure FSH and FSH/HMG respectively (P <0.05). The significantly higher number of immature oocytes matured in vitro in the FSH/HMG group (P = 0.001) suggests a possible effect on in-vitro maturation, due to luteinizing hormone present in HMG. The difference in mature oocyte quality may be an important determinant in the higher pregnancy rates for the FSH-stimulated patients.

Original languageEnglish (US)
Pages (from-to)1886-1889
Number of pages4
JournalHuman Reproduction
Volume12
Issue number9
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Menotropins
Follicle Stimulating Hormone
Oocytes
Pregnancy Rate
Leuprolide
Age Factors
Chorionic Gonadotropin
Luteinizing Hormone
Ovulation
Fertilization
Infertility
Estradiol
Down-Regulation
Embryonic Structures

Keywords

  • HMG
  • Oocyte quality
  • Pregnancy rates
  • Pure FSH

ASJC Scopus subject areas

  • Physiology
  • Developmental Biology
  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination. / Mercan, Ramazan; Mayer, Jacob F.; Walker, Denise; Jones, Stella; Oehninger, Sergio; Toner, James P.; Muasher, Suheil J.

In: Human Reproduction, Vol. 12, No. 9, 1997, p. 1886-1889.

Research output: Contribution to journalArticle

Mercan, Ramazan ; Mayer, Jacob F. ; Walker, Denise ; Jones, Stella ; Oehninger, Sergio ; Toner, James P. ; Muasher, Suheil J. / Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination. In: Human Reproduction. 1997 ; Vol. 12, No. 9. pp. 1886-1889.
@article{69138ff0b31b44d298bf1210660c2ace,
title = "Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination",
abstract = "The aim of this study was to compare the efficacy of pure follicle stimulating hormone (FSH) with that of FSH/human menopausal gonadotrophin (HMG) combination in downregulated cycles. A total of 357 patients was evaluated retrospectively. Sixty percent of patients in the FSH group and 55{\%} in the FSH/HMG group were new; the others were repeat patients. Ovulation was suppressed with leuprolide acetate in all patients, followed by either FSH (n = 218) or FSH/HMG (n = 119). There was no difference in patients' age, infertility factors, number of ampoules used, length of stimulation, oestradiol levels on day of human chorionic gonadotrophin (HCG) administration, number of oocytes recovered or the number of embryos transferred. Also, nuclear maturity at aspiration and fertilization rates were not different between the two groups. FSH stimulation resulted in a significantly higher percentage of mature oocytes that showed the typical 'mature' morphological characteristics (P <0.0001). The clinical pregnancy rates per transfer were 40 and 28{\%} in patients stimulated with pure FSH and FSH/HMG respectively (P <0.05). The significantly higher number of immature oocytes matured in vitro in the FSH/HMG group (P = 0.001) suggests a possible effect on in-vitro maturation, due to luteinizing hormone present in HMG. The difference in mature oocyte quality may be an important determinant in the higher pregnancy rates for the FSH-stimulated patients.",
keywords = "HMG, Oocyte quality, Pregnancy rates, Pure FSH",
author = "Ramazan Mercan and Mayer, {Jacob F.} and Denise Walker and Stella Jones and Sergio Oehninger and Toner, {James P.} and Muasher, {Suheil J.}",
year = "1997",
doi = "10.1093/humrep/12.9.1886",
language = "English (US)",
volume = "12",
pages = "1886--1889",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination

AU - Mercan, Ramazan

AU - Mayer, Jacob F.

AU - Walker, Denise

AU - Jones, Stella

AU - Oehninger, Sergio

AU - Toner, James P.

AU - Muasher, Suheil J.

PY - 1997

Y1 - 1997

N2 - The aim of this study was to compare the efficacy of pure follicle stimulating hormone (FSH) with that of FSH/human menopausal gonadotrophin (HMG) combination in downregulated cycles. A total of 357 patients was evaluated retrospectively. Sixty percent of patients in the FSH group and 55% in the FSH/HMG group were new; the others were repeat patients. Ovulation was suppressed with leuprolide acetate in all patients, followed by either FSH (n = 218) or FSH/HMG (n = 119). There was no difference in patients' age, infertility factors, number of ampoules used, length of stimulation, oestradiol levels on day of human chorionic gonadotrophin (HCG) administration, number of oocytes recovered or the number of embryos transferred. Also, nuclear maturity at aspiration and fertilization rates were not different between the two groups. FSH stimulation resulted in a significantly higher percentage of mature oocytes that showed the typical 'mature' morphological characteristics (P <0.0001). The clinical pregnancy rates per transfer were 40 and 28% in patients stimulated with pure FSH and FSH/HMG respectively (P <0.05). The significantly higher number of immature oocytes matured in vitro in the FSH/HMG group (P = 0.001) suggests a possible effect on in-vitro maturation, due to luteinizing hormone present in HMG. The difference in mature oocyte quality may be an important determinant in the higher pregnancy rates for the FSH-stimulated patients.

AB - The aim of this study was to compare the efficacy of pure follicle stimulating hormone (FSH) with that of FSH/human menopausal gonadotrophin (HMG) combination in downregulated cycles. A total of 357 patients was evaluated retrospectively. Sixty percent of patients in the FSH group and 55% in the FSH/HMG group were new; the others were repeat patients. Ovulation was suppressed with leuprolide acetate in all patients, followed by either FSH (n = 218) or FSH/HMG (n = 119). There was no difference in patients' age, infertility factors, number of ampoules used, length of stimulation, oestradiol levels on day of human chorionic gonadotrophin (HCG) administration, number of oocytes recovered or the number of embryos transferred. Also, nuclear maturity at aspiration and fertilization rates were not different between the two groups. FSH stimulation resulted in a significantly higher percentage of mature oocytes that showed the typical 'mature' morphological characteristics (P <0.0001). The clinical pregnancy rates per transfer were 40 and 28% in patients stimulated with pure FSH and FSH/HMG respectively (P <0.05). The significantly higher number of immature oocytes matured in vitro in the FSH/HMG group (P = 0.001) suggests a possible effect on in-vitro maturation, due to luteinizing hormone present in HMG. The difference in mature oocyte quality may be an important determinant in the higher pregnancy rates for the FSH-stimulated patients.

KW - HMG

KW - Oocyte quality

KW - Pregnancy rates

KW - Pure FSH

UR - http://www.scopus.com/inward/record.url?scp=0030733886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030733886&partnerID=8YFLogxK

U2 - 10.1093/humrep/12.9.1886

DO - 10.1093/humrep/12.9.1886

M3 - Article

C2 - 9363700

AN - SCOPUS:0030733886

VL - 12

SP - 1886

EP - 1889

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 9

ER -